Terms: = Ovarian cancer AND PCM1, Q15154, PTC4, ENSG00000078674, 5108 AND Treatment
4 results:
1. Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.
Charpentier AM; Chong AL; Gingras-Hill G; Ahmed S; Cigsar C; Gupta AA; Greenblatt E; Hodgson DC
J Cancer Surviv; 2014 Dec; 8(4):548-54. PubMed ID: 24810980
[TBL] [Abstract] [Full Text] [Related]
2. Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies.
Chinn DC; Holland WS; Mack PC
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1137-49. PubMed ID: 24756365
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway.
Chefetz I; Holmberg JC; Alvero AB; Visintin I; Mor G
Cell Cycle; 2011 Jul; 10(13):2206-14. PubMed ID: 21623171
[TBL] [Abstract] [Full Text] [Related]
4. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
Hahn HS; Yoon SG; Hong JS; Hong SR; Park SJ; Lim JY; Kwon YS; Lee IH; Lim KT; Lee KH; Shim JU; Mok JE; Kim TJ
Int J Gynecol Cancer; 2009 Aug; 19(6):1068-73. PubMed ID: 19820370
[TBL] [Abstract] [Full Text] [Related]
